X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2356) 2356
Book Review (458) 458
Publication (126) 126
Newsletter (43) 43
Magazine Article (16) 16
Newspaper Article (9) 9
Book Chapter (4) 4
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1914) 1914
humans (1821) 1821
minocycline (1139) 1139
female (1019) 1019
male (989) 989
minocycline - adverse effects (970) 970
minocycline - therapeutic use (759) 759
adult (708) 708
anti-bacterial agents - adverse effects (668) 668
middle aged (543) 543
anti-bacterial agents - therapeutic use (527) 527
minocycline - administration & dosage (402) 402
animals (387) 387
aged (354) 354
adolescent (326) 326
treatment outcome (317) 317
pharmacology & pharmacy (314) 314
anti-bacterial agents - administration & dosage (303) 303
minocycline - pharmacology (303) 303
minocycline - analogs & derivatives (300) 300
acne vulgaris - drug therapy (296) 296
abridged index medicus (265) 265
dermatology (244) 244
infectious diseases (227) 227
antibiotics (223) 223
therapy (199) 199
microbiology (192) 192
anti-bacterial agents - pharmacology (179) 179
neurosciences (178) 178
tigecycline (171) 171
drug therapy (170) 170
care and treatment (165) 165
drug therapy, combination (161) 161
acne (153) 153
tetracycline (149) 149
rats (145) 145
doxycycline (144) 144
analysis (143) 143
efficacy (143) 143
health aspects (143) 143
research (140) 140
infections (138) 138
medicine, general & internal (138) 138
mice (138) 138
dentistry (135) 135
time factors (135) 135
tetracyclines (130) 130
inflammation (122) 122
pigmentation disorders - chemically induced (121) 121
disease models, animal (120) 120
clinical trials (117) 117
double-blind (117) 117
risk factors (117) 117
clinical neurology (116) 116
tetracyclines - adverse effects (115) 115
microbial sensitivity tests (114) 114
surgery (114) 114
young adult (108) 108
immunology (106) 106
aged, 80 and over (105) 105
disease (103) 103
administration, oral (102) 102
hyperpigmentation - chemically induced (101) 101
double-blind method (100) 100
drugs (100) 100
dosage and administration (97) 97
microglia (97) 97
child (94) 94
follow-up studies (94) 94
medicine & public health (94) 94
dentistry, oral surgery & medicine (92) 92
skin (92) 92
complications and side effects (90) 90
diagnosis, differential (90) 90
dose-response relationship, drug (89) 89
retrospective studies (88) 88
safety (87) 87
medical research (84) 84
in-vitro (82) 82
diagnosis (78) 78
minocycline - pharmacokinetics (78) 78
rheumatology (77) 77
internal medicine (73) 73
pigmentation (72) 72
brain (71) 71
prevention (70) 70
neuroprotection (68) 68
usage (68) 68
article (67) 67
bacterial infections - drug therapy (67) 67
infection (67) 67
anti-bacterial agents - pharmacokinetics (66) 66
drug eruptions - etiology (65) 65
drug resistance, multiple, bacterial (65) 65
dermatology & venereal diseases (64) 64
microglial activation (64) 64
bacteria (63) 63
rats, sprague-dawley (63) 63
infectious disease (62) 62
neurology (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2241) 2241
French (66) 66
Japanese (39) 39
German (24) 24
Spanish (18) 18
Dutch (11) 11
Hebrew (6) 6
Chinese (5) 5
Italian (3) 3
Russian (3) 3
Korean (2) 2
Czech (1) 1
Norwegian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Case Reports in Gastroenterology, ISSN 1662-0631, 08/2018, Volume 12, Issue 2, pp. 447 - 452
Drug-induced autoimmune hepatitis is an acute and potentially severe adverse effect, which has been reported following the long-term use of minocycline. The... 
Single Case | Minocycline | Drug-induced liver injury | Autoimmune hepatitis | Drug-induced hepatitis
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 03/2018, Volume 70, Issue 3, pp. 468 - 474
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2013, Volume 43, Issue 1, pp. 52 - 59
Abstract Fosfomycin is active in vitro against extensively drug-resistant (XDR) and pandrug-resistant (PDR) Pseudomonas aeruginosa and Klebsiella pneumoniae... 
Infectious Disease | Klebsiella | Pseudomonas | Critically ill | XDR | Fosfomycin | PDR | DEFINITION | MORTALITY | INFECTIOUS DISEASES | COMBINATION THERAPY | MICROBIOLOGY | INTRAVENOUS FOSFOMYCIN | K.-PNEUMONIAE | IMPACT | PREDICTORS | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Klebsiella pneumoniae - drug effects | Prospective Studies | Humans | Middle Aged | Minocycline - analogs & derivatives | Critical Illness | Male | Bacterial Proteins - secretion | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Minocycline - adverse effects | Minocycline - therapeutic use | Pseudomonas aeruginosa - enzymology | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Adult | Colistin - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Intensive Care Units | Fosfomycin - therapeutic use | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Fosfomycin - adverse effects | Treatment Outcome | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | beta-Lactamases - secretion | Administration, Intravenous | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Aged | Care and treatment | Pneumonia | Microbiology | Patient outcomes | Analysis | Bacterial pneumonia | Mortality | Bacteria | Drug resistance | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 02/2015, Volume 313, Issue 6, pp. 584 - 593
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2014, Volume 69, Issue 7, pp. 1945 - 1953
We report the largest clinical experience using tigecycline-containing regimens for salvage treatment of patients with Mycobacterium abscessus and... 
Atypical mycobacterial infections | Non-tuberculous mycobacteria | Cystic fibrosis | Pulmonary | ANTIMICROBIAL SUSCEPTIBILITY | INFECTIOUS DISEASES | EFFICACY | NONTUBERCULOUS MYCOBACTERIA | SAFETY | pulmonary | MICROBIOLOGY | PHASE-3 | RAPIDLY GROWING MYCOBACTERIA | atypical mycobacterial infections | FORTUITUM | SKIN-STRUCTURE INFECTIONS | cystic fibrosis | COMPLICATED INTRAABDOMINAL INFECTIONS | non-tuberculous mycobacteria | PHARMACOLOGY & PHARMACY | VANCOMYCIN-AZTREONAM | Salvage Therapy - adverse effects | Antitubercular Agents - adverse effects | Nausea - chemically induced | Humans | Middle Aged | Minocycline - analogs & derivatives | Male | Nausea - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Minocycline - adverse effects | Minocycline - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Aged, 80 and over | Adult | Female | Child | Antitubercular Agents - therapeutic use | Treatment Outcome | Drug-Related Side Effects and Adverse Reactions - epidemiology | Nontuberculous Mycobacteria - isolation & purification | Drug Therapy, Combination - methods | Adolescent | Aged | Mycobacterium Infections, Nontuberculous - drug therapy | Salvage Therapy - methods | Bacterial infections | Pulmonary fibrosis | Medical treatment | Index Medicus | Original Research
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 10/2007, Volume 69, Issue 14, pp. 1404 - 1410
Journal Article
The Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2008, Volume 62, Issue suppl_1, pp. i17 - 28
Journal Article